Clinical trials
Phase 2 Homozygous Familial Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Suncadia Pharmaceuticals Co., Ltd | 2 |
| Kastle Therapeutics, LLC | 2 |
| Aegerion Pharmaceuticals, Inc. | 1 |
| Akcea Therapeutics | 1 |
| Akeso | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Cerenis Therapeutics, SA | 1 |
| Eddingpharm (Zhuhai) Co., Ltd. | 1 |
| Gilead Sciences | 1 |
| Medical Research Laboratories International | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homozygous Familial Hypercholesterolemia | 14 |
| Hyperlipoproteinemia Type II | 4 |
| Dyslipidemias | 2 |
| Congenital Abnormalities | 1 |
| Genetic Diseases, Inborn | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Hyperlipoproteinemias | 1 |
| Infant, Newborn, Diseases | 1 |
| Lipid Metabolism Disorders | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.